According to the World Health Organisation (WHO), exclusive breastfeeding for the first six months of an infant’s life is the cornerstone of good health and survival.
Stasha Jordan, Executive Director of the South African Breastmilk Reserve, points out that breastmilk helps to reduce infections by strengthening these babies’ immune systems. “This is even more important for babies born prematurely and of very low birth weight.”
Research has shown that infants who are not breastfed have a much higher risk of developing respiratory infections, diarrhoeal disease, allergies and asthma. The risk of ear infections has also been shown to be four times greater in the first year of life in babies who are formula fed. It has also been shown that breastmilk contains the perfect nutrients for a baby’s brain to grow to its maximum potential and babies who were breastfed scored higher on intelligence tests.
A study published in the Lancet in 2013 indicated that optimal breast feeding of infants under two years of age has the potential to prevent over 800,000 deaths per year, 13% of all deaths in children under five in the developing world.
Jordan says that unfortunately not all infants have access to breastmilk and local health authorities attribute low rates of exclusive breast feeding to the prevalence of poverty and to misinformation.
According to a study by South African medical researchers , formally employed HIV negative mothers were twice as likely to stop breast feeding by 12 weeks. In this study, most of the women had little or no maternity leave provision. Soon after giving birth, many poor mothers need to get working again. What little income they earned went towards purchasing formula milk instead.
Jordan says that the study also indicated the early introduction of formula milk and a steady increase in breast feeding cessation amongst HIV negative women could not be prevented, despite postnatal home visits from peer breast feeding counsellors. “The researchers remarked that this scenario is unique to South Africa. The use of formula milk within the first six months of an infant’s life is uncommon in other parts of continent.”
Jordan explains that breast milk banks can play a vital role in supporting breastmilk feeding in South Africa, however, it is important to carefully consider the regulations around milk banking in South Africa.
The South African Department of Health is currently developing regulations on milk banking. While some of the existing milk banks follow standards and guidelines set by the Human Milk Banking Association of South Africa, for processing and pasteurizing, others follow the SABR guidelines modelled on the NICE guidelines for human milk banking. They operate independently using different funding mechanisms to meet community needs . Three human milk bank models, all of which are not-for-profit, are found in South Africa.
Jordan says that the ethical distribution and capacity management of Donated Breast-Milk (DBM) for the NICU in hospitals have become key focus areas in the breastfeeding and healthcare sectors.
She says that the current regulatory framework for human milk banking in South Africa gives us an opportunity to reflect on the importance of treating DBM in accordance with the ethical standard that guides the human tissue and organ donation sector. “Ten years into active human milk banking at the hospital level, we are witnessing a growing desire of prescribing doctors to exceed the current DBM user guidelines.”
Jordan says that an equitable allocation system for donated breastmilk that takes into consideration utility, justice and respect for person, should drive the ethical considerations that pertain to universal access and distribution of donated breastmilk.
“The current regulatory framework for human milk banking gives us the opportunity to reflect on the importance of treating donated breastmilk in accordance with the ethical standards that inform the human tissue and organ donor sector. Stakeholders in human milk banking in South Africa have differing views on whether access to this tissue should be a right or a privilege,” says Jordan.
Professor Morgan Chetty, CEO of the KwaZulu Natal Managed Care Coalition Ltd and Chairman of the IPA Foundation of SA, says that there are three ethical issues that also need to guide the use of human milk that is banked; decision making, informed consent, and conflict of interest. “In the first instance, decision making is currently guided by a combination of the best available scientific evidence, clinical experience and consideration of the needs of individual patients. If donor milk is available and the evidence of human milk’s advantage over commercial formula feeding is universally accepted, the clinician’s decision should be to support the choice of mother’s milk.”
Chetty adds that clinicians must also provide information about current state of knowledge of mother’s milk as part of informed consent process for infant feeds. “There is also the issue of market incentives to use commercial formula. Healthcare providers should disclose any relationship with entities that could influence their recommendations or discussions with the parents.
“In the face of increasing need for human breast milk, it is important that we work to overcome the ‘negative’ attitude and misperception South African women have towards breast feeding. Improving access to breast milk banking is one step in the right direction. However, we need to carefully consider the ethical considerations of breast milk banking to prevent hurting the same infants we are looking to protect,” concludes Jordan.
Jordan and Chetty will both be speaking at the Ethics, Human Rights & Medical Law conference, which will form part of the 7th annual Africa Health Exhibition & Congress 2017 taking place from 7-9 June 2017 at the Gallagher Convention Centre in Johannesburg, South Africa. More than 9,300 regional and international healthcare professionals and medical experts are expected to attend the event.
Conference cost: ranges from R150 – R300. Email: firstname.lastname@example.org, www.informalifesciences.com
More about Informa Life Science Exhibitions:
Informa Life Sciences Exhibitions, in charge of the healthcare portfolio within Informa’s Global Exhibitions division, organises 26 exhibitions yearly covering the Middle East, Africa, Asia, Europe and US market, connecting more than 150,000 healthcare professionals worldwide and offering a range of marketing solutions for companies involved with the healthcare sector. Over 100 congresses take place in parallel with the exhibitions.
Informa Life Sciences Exhibitions have a number of digital and print offerings, publishing a variety of healthcare magazines and medical directories, with a readership of top decision-makers in the MENA region’s healthcare industry. Additionally, Omnia, the global medical directory, is a unique digital platform providing company and product information 365 days of the year, allowing users to connect with exhibitors and products in one simple click.
[With thanks to New Age and Die Burger newspapers, for their coverage of this story.]